GenMedicn Biopharma
GenMedicn is a gene therapy drug development company dedicated to popularizing gene therapy drugs to normalized application scenarios.
GenMedicn Biopharma is a company based in Nanjing, China. Recent Funding lists it under Health and bio. Its latest known round is a Series A round (October 2026); no sourced amount is on record for it yet. Investors on record for it include Broadcom Capital, Enran Chuangtou, Huade Science and Technology, Kangyuan Huiying and 2 others. It was founded by Huang Yue, Tung Wen-chi and Zhang Yip.
Funding rounds
- Series A · amount undisclosedHHuade Science and Technology (lead), BBroadcom Capital,
EEnran Chuangtou,
KKangyuan Huiying,
LLongmen Capital
Source: m.sohu.com
Founders and team
HY
Huang Yue FounderTW
Tung Wen-chi FounderZY
Zhang Yip Founder
Investors
- BBroadcom Capital
- HHuade Science and Technologylead investor
PPuhua Capital
GenMedicn Biopharma: questions and answers
- Who invested in GenMedicn Biopharma?
- Investors on record for GenMedicn Biopharma: Broadcom Capital, Enran Chuangtou, Huade Science and Technology, Kangyuan Huiying, Longmen Capital and Puhua Capital. Huade Science and Technology led a round.
- Who founded GenMedicn Biopharma?
- GenMedicn Biopharma was founded by Huang Yue, Tung Wen-chi and Zhang Yip.
- Where is GenMedicn Biopharma based?
- GenMedicn Biopharma is based in Nanjing, China.
Similar Health and bio companies
OOutro Health$7M Seed · Oct 2026
AAlo Hakeem$165K Pre Seed · Oct 2026
NNat Habit$14.68M Series B+ · Oct 2026GGramiyaa$1.93M Series A · Oct 2026
PPhantom GI$5M Seed · Oct 2026WWelltory$2M Seed · Oct 2026
Every amount links to the page it came from. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/genmedicn-biopharma (get a free API key).